Post by Genedata

In this new interview with Technology Networks from American Society For Mass Spectrometry (ASMS) 2026, Genedata's Aude Tartiere discusses how automation is transforming peptide mapping, cutting validation time while keeping scientific oversight intact — plus why open, integrated systems (not "black box" tools) are key to turning MS data into real decisions.   Read the full interview: https://lnkd.in/dyNtWPcg